ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,374Medicare Part D Prescriptions Filled, Including Refills

Rank: 712 out of 3035

$561K Total Retail Price of All Prescriptions

Rank: 939 out of 3035

599 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Texas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 395 367 91 S3 1 5
AMLODIPINE BESYLATE 372 341 77 2 2
SIMVASTATIN 363 358* 88 3 4
LEVOTHYROXINE SODIUM 267 248 61 4 1
METFORMIN HCL 264 217 52 5 9
LISINOPRIL 247 222 52 6 3
POTASSIUM CHLORIDE 229 204 56 7 15
ATENOLOL 225 200 43 8 32
ALPRAZOLAM 222 190 50 B 9 19
FUROSEMIDE 213 208* 55 10 7
ATORVASTATIN CALCIUM 210 195 47 11 6
SERTRALINE HCL 190 185* 35 12 26
OMEPRAZOLE 172 167* 44 13 8
METOPROLOL TARTRATE 161 156* 33 14 10
METOPROLOL SUCCINATE 160 128 34 15 13
LOSARTAN POTASSIUM 158 153* 28 16 14
CLOPIDOGREL 157 157 26 17 18
HYDROCHLOROTHIAZIDE 139 134* 32 18 16
WARFARIN SODIUM 136 116 29 19 25
TRIAMTERENE-HCTZ 129 115 30 20 68
ALLOPURINOL 127 122* 24 21 38
AMLODIPINE BESYLATE-BENAZEPRIL 127 114 23 21 71
NEXIUM 122 109 31 23 20
METFORMIN HCL ER 119 105 23 24 54
GABAPENTIN 116 111* 22 25 12
PRAVASTATIN SODIUM 108 103* 24 26 11
AZITHROMYCIN 107 85 91 27 46
PANTOPRAZOLE SODIUM 107 89 19 27 24
MELOXICAM 95 82 26 29 35
LORAZEPAM 83 71 28 B 30 47
DIOVAN 83 78* 18 30 36
MICARDIS 82 <11 <11 32 344
CELEBREX 80 80 14 33 74
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 70* 19 34 34
GLIMEPIRIDE 73 68* 15 35 37
CRESTOR 71 66* 12 36 22
TEMAZEPAM 71 66* 17 B 36 72
TRAMADOL HCL 70 55 26 38 17
VERAPAMIL ER 66 55 13 39 113
ZOLPIDEM TARTRATE 65 60* 17 40 23
MIRTAZAPINE 65 65 12 40 62
QUINAPRIL HCL 65 60* 16 40 182
DIGOX 60 60 16 43 100
LOSARTAN-HYDROCHLOROTHIAZIDE 59 59 11 44 43
LOVASTATIN 58 53* 16 45 52
CITALOPRAM HBR 58 53* 15 45 29
FLUTICASONE PROPIONATE 53 48* 15 47 33
CARVEDILOL 53 53 12 47 21
BISOPROLOL-HYDROCHLOROTHIAZIDE 53 53 12 47 183
LANTUS 53 27 11 47 56
QUETIAPINE FUMARATE 53 53 12 A 47 53
PREDNISONE 53 48* 23 47 45
TORSEMIDE 52 52 12 53 159
CLONAZEPAM 51 <11 <11 B 54 58
DIGOXIN 51 <11 <11 54 147
VYTORIN 50 <11 <11 56 157
ADVAIR DISKUS 50 39 14 56 66
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2015.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.